IP Library Granted Patent US 8,221,998
Granted Patent B2
US 8,221,998 · App. 11/914,953 · Granted Jul 17, 2012

Expression of protein GB1 domain fusion proteins in mammalian cells

Assignee: GlaxoSmithKline LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,221,998
App. No.
11/914,953
Granted
Jul 17, 2012
Kind
B2
Abstract

This present invention relates to the use of the B1 domain of Protein G as an epitope tag for over-expression of proteins in mammalian cells.

Claims (11)

1. A method for expressing a polypeptide in a mammalian recombinant host cell, said method comprising

culturing the host cell under an appropriate condition, wherein said host cell comprises an expression vector comprising at least one GB1 polynucleotide directly or indirectly linked to a polynucleotide encoding said polypeptide, wherein said at least one GB1 polynucleotide comprises SEQ ID NO: 6, and

purifying such polypeptide.

2. The method of claim 1 , wherein said host cell is a Chinese Hamster Ovary cell.

3. The method of claim 1 , wherein said host cell is a Chinese Hamster Ovary cell containing an adenovirus E1A gene.

4. The method of claim 1 , wherein said host cell is a COS or HEK cell.

5. The method of claim 1 , wherein said at least one GB1 polynucleotide is linked directly or indirectly to the 3′ terminus of the polynucleotide encoding said polypeptide.

6. The method of claim 1 , wherein said at least one GB1 polynucleotide is linked to said polynucleotide encoding said polypeptide via a polynucleotide encoding a selectable cleavage site.

7. The method of claim 6 , wherein said selectable cleavage site comprises tobacco etch virus protease cleavage site.

8. The method of claim 6 , further comprising cleaving said selectable cleavage site prior to purifying said polypeptide.

9. The method of claim 1 in which said polypeptide is Cholesterol Ester Transfer protein or Endothelial Lipase protein.

Assignments (2)
CHANGE OF NAME Recorded Sep 20, 2013
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 031247/0015 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2007
From: JOHANSON, KYUNG OH; TRILL, JOHN J.
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 020137/0544 →
Continuity (2)
Provisional Application 60683254 · May 20, 2005
Related Publication 20090148892A1 · Jun 11, 2009